Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

V2X, INC. (VVX)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

V2X and Elastic Partner to Strengthen Search and Agentic Analytics Across Government Mission Workflows

Market reaction Comment Full text

QUIPT HOME MEDICAL CORP. (QIPT)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

Market reaction Comment Full text

SIGNING DAY SPORTS, INC. COMMON STOCK (SGN)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Signing Day Sports and BlockchAIn Provide Update on Expected Ticker Symbol Transition and Common Stock Trading Schedule

Market reaction Comment Full text

ZEVRA THERAPEUTICS, INC. (ZVRA)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 0
  • 1 comments

Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

Market reaction Comment Full text

MEDICUS PHARMA LTD. (MDCX)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

Market reaction Comment Full text

SIRIUSPOINT LTD. (SPNT)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

SiriusPoint Announces Creation of Global P&C Programs and London Market Specialty Divisions

Market reaction Comment Full text

NASUS PHARMA LTD. (NSRX)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

Market reaction Comment Full text

ENLIGHT RENEWABLE ENERGY LTD. (ENLT)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Enlight Secures $304 Million in Project Financing for the Crimson Orchard Project in Idaho, USA

Market reaction Comment Full text

BIOCERES CROP SOLUTIONS CORP. (BIOX)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

A Message from Our Chief Executive Officer

Market reaction Comment Full text

AMERICAN INTEGRITY INSURANCE GROUP, INC. COMMON STOCK (AII)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Almonty Completes Phase 1 of Sangdong Tungsten Mine in South Korea

Market reaction Comment Full text

FERGUSON ENTERPRISES INC. (FERG)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Ferguson Files Definitive Proxy Materials and Transition Report

Market reaction Comment Full text

AGENUS INC. (AGEN)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 0
  • 1 comments

Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

Market reaction Comment Full text

PALVELLA THERAPEUTICS, INC. (PVLA)

  • Business News
  • March 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Market reaction Comment Full text

HALEON PLC (HLN)

  • Event
  • March 16, 2026, 11:22 UTC
  • 0
  • 1 comments

HALEON PLC (HLN) Files Form 6-K

Comment Full text

Dyadic International Inc. (DYAI)

  • Business News
  • March 16, 2026, 11:20 UTC
  • 1
  • 1 comments

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Market reaction Comment Full text
  • Previous
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next

Search

News categories

  • Technical Exchange News(11248)
  • Event(2611)
  • SEC News(198350)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131355)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin